6,8-difluoro-4-methylumbelliferyl phosphate
a fluorescent substrate of protein phosphatases 1 and 2A
Also Known As:
6,8-difluoro-MUP; DIFMUP
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Chung, Sang J:
1 article
(12/2018)
|
| 2. | Durgannavar, Trishaladevi:
1 article
(12/2018)
|
| 3. | Ghisaidoobe, Amar B T:
1 article
(12/2018)
|
| 4. | Kang, Hyo Jin:
1 article
(12/2018)
|
| 5. | Kim, Ju Hwan:
1 article
(12/2018)
|
| 6. | Kwon, Se Jeong:
1 article
(12/2018)
|
| 7. | Rho, Kyungmin:
1 article
(12/2018)
|
| 8. | Yoon, Sun-Young:
1 article
(12/2018)
|
| 9. | Böhmer, Frank-D:
1 article
(05/2015)
|
| 10. | Henklein, Petra:
1 article
(05/2015)
|
Related Diseases
| 1. | Carcinoma (Carcinomatosis)
12/04/2018
- " In contrast to 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP), a representative fluorescence turn-on PTP substrate, our FRET probe successfully differentiated human cervical carcinoma cell lysate, SiHa, which has a high expression level of PTP1B, from PTP1B-knockdown SiHa cell lysate (that is, siRNA was used for PTP1B knockdown)." 05/01/2015
- " Using Hep3B liver carcinoma cells, RTK activation was assessed by Western blot employing phospho-RTK specific antibodies, ROS level were estimated by H2DCF-DA using confocal laser scanning microscopy, and measurement of PTP activity was performed in cell lysates using 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP) as a substrate. "
|
|
Related Drugs and Biologics
Related Therapies and Procedures